These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3755281)

  • 21. Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
    Murray N; Coppin C; Coldman A; Pater J; Rapp E
    J Clin Oncol; 1994 Nov; 12(11):2333-9. PubMed ID: 7964949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
    Weick JK; Crowley J; Natale RB; Hom BL; Rivkin S; Coltman CA; Taylor SA; Livingston RB
    J Clin Oncol; 1991 Jul; 9(7):1157-62. PubMed ID: 1646292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial.
    Eagan RT; Therneau TM; Rubin J; Long HJ; Schutt AJ
    Am J Clin Oncol; 1987 Feb; 10(1):82-5. PubMed ID: 3548315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer.
    Niell HB; Griffin JP
    Med Pediatr Oncol; 1985; 13(6):341-5. PubMed ID: 3930930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer.
    Umsawasdi T; Valdivieso M; Barkley HT; Booser DJ; Chiuten DF; Murphy WK; Dhingra HM; Dixon CL; Farha P; Spitzer G
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):511-9. PubMed ID: 3838297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
    Feld R; Rubinstein L; Thomas PA
    Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
    Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer.
    Niell HB; Griffin JP; West WH; Neely CL
    Cancer; 1984 Oct; 54(7):1260-3. PubMed ID: 6088022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
    Nomura F; Shimokata K; Saito H; Sakai S; Watanabe A; Saka H
    Cancer Chemother Pharmacol; 1987; 20(4):324-6. PubMed ID: 2826032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
    Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
    Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
    Ichinose Y; Hara N; Ohta M; Motohiro A; Kuda T; Aso H
    J Surg Oncol; 1991 Jan; 46(1):15-20. PubMed ID: 1702493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP).
    Hainsworth JD; Jones HW; Burnett LS; Johnson DH; Greco FA
    Am J Clin Oncol; 1990 Oct; 13(5):410-5. PubMed ID: 2121019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
    Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study.
    Miller TP; Chen TT; Coltman CA; O'Bryan RM; Vance RB; Weiss GB; Fletcher WS; Stephens RL; Livingston RB
    J Clin Oncol; 1986 Apr; 4(4):502-8. PubMed ID: 3007683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.
    Davis S; Tonato M; Crinò L; Colozza MA; Lubansky K; Grignani F
    Cancer; 1986 Sep; 58(5):1018-9. PubMed ID: 3015372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy followed by radiation therapy in patients with regional stage III unresectable non-small cell lung cancer.
    Fram R; Skarin A; Balikian J; Amato D; Leslie N; Malcolm A; Frei E
    Cancer Treat Rep; 1985 Jun; 69(6):587-90. PubMed ID: 2990710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer].
    Hernádi Z; Juhász B; Póka R; Mahunka I; Lampé L
    Orv Hetil; 1987 Nov; 128(47):2457-61. PubMed ID: 3320851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.